Literature DB >> 17972042

Evaluation of anxiety in Parkinson's disease with some commonly used rating scales.

F Mondolo1, M Jahanshahi, A Granà, E Biasutti, E Cacciatori, P Di Benedetto.   

Abstract

This study assessed the concurrent validity of the State-Trait Anxiety Inventory (STAI), the Hospital Anxiety and Depression Scale (HADS) and the Hamilton Anxiety Scale (Ham-A) for evaluating anxiety in a group of 46 Parkinson's disease (PD) patients. The magnitude of correlations between the scales was high (all p<0.01), indicating a good concurrent validity. The item-by item analysis indicated that the main characteristics of anxiety in PD patients were 'inability to relax', 'restlessness or inability to feel calm' and 'feeling tense'. The association between anxiety, as measured by the HADS-A, with demographic characteristics or clinical features of PD was not significant, supporting existing data suggesting that anxiety in PD is not closely correlated with the severity of motor symptoms or the degree of disability. The HADS-A may be the most appropriate scale for documenting patient-reported anxiety in depression.

Entities:  

Mesh:

Year:  2007        PMID: 17972042     DOI: 10.1007/s10072-007-0834-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  24 in total

1.  Psychosocial problems of Parkinson patients: approaches to assessment and treatment.

Authors:  H Ellgring; S Seiler; U Nagel; B Perleth; T Gasser; W H Oertel
Journal:  Adv Neurol       Date:  1990

2.  Prospective assessment of falls in Parkinson's disease.

Authors:  B R Bloem; Y A Grimbergen; M Cramer; M Willemsen; A H Zwinderman
Journal:  J Neurol       Date:  2001-11       Impact factor: 4.849

3.  Anxiety disorders in familial parkinsonism.

Authors:  E C Lauterbach; R C Duvoisin
Journal:  Am J Psychiatry       Date:  1991-02       Impact factor: 18.112

4.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 6.  Anxiety and Parkinson's disease.

Authors:  I H Richard; R B Schiffer; R Kurlan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

7.  Parkinson's disease and anxiety: comorbidity with depression.

Authors:  M A Menza; D E Robertson-Hoffman; A S Bonapace
Journal:  Biol Psychiatry       Date:  1993-10-01       Impact factor: 13.382

8.  Anxiety disorders in patients with Parkinson's disease.

Authors:  M B Stein; I J Heuser; J L Juncos; T W Uhde
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

9.  Depression in Parkinson's disease: a quantitative and qualitative analysis.

Authors:  A M Gotham; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

10.  Evidence for atypical depression in Parkinson's disease.

Authors:  R B Schiffer; R Kurlan; A Rubin; S Boer
Journal:  Am J Psychiatry       Date:  1988-08       Impact factor: 18.112

View more
  21 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 2.  Anxiety in Parkinson's disease: identification and management.

Authors:  Jack J Chen; Laura Marsh
Journal:  Ther Adv Neurol Disord       Date:  2014-01       Impact factor: 6.570

3.  Motion and emotion: anxiety-axial connections in Parkinson's disease.

Authors:  Rastislav Šumec; Irena Rektorová; Robert Jech; Kateřina Menšíková; Jan Roth; Evžen Růžička; Dana Sochorová; Ladislav Dušek; Petr Kaňovský; Ivan Rektor; Tomáš Pavlík; Pavel Filip; Martin Bareš
Journal:  J Neural Transm (Vienna)       Date:  2016-11-23       Impact factor: 3.575

Review 4.  Neuropsychiatric aspects of Parkinson's disease.

Authors:  Anna Nagy; Anette Schrag
Journal:  J Neural Transm (Vienna)       Date:  2019-05-29       Impact factor: 3.575

5.  The impact of motor symptoms on self-reported anxiety in Parkinson's disease.

Authors:  Robert D Salazar; Asher M Le; Sandy Neargarder; Alice Cronin-Golomb
Journal:  Parkinsonism Relat Disord       Date:  2017-01-24       Impact factor: 4.891

6.  Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene.

Authors:  Anat Mirelman; Roy N Alcalay; Rachel Saunders-Pullman; Kira Yasinovsky; Avner Thaler; Tanya Gurevich; Helen Mejia-Santana; Deborah Raymond; Mali Gana-Weisz; Anat Bar-Shira; Laurie Ozelius; Lorraine Clark; Avi Orr-Urtreger; Susan Bressman; Karen Marder; Nir Giladi
Journal:  Mov Disord       Date:  2015-03-21       Impact factor: 10.338

Review 7.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

8.  Predictors of an unfavorable outcome 1.5 and 12 years after a first, uncomplicated lumbar disc surgery.

Authors:  Karin Pieber; Nora Salomon; Silke Inschlag; Gabriele Amtmann; Karl-Ludwig Resch; Gerold Ebenbichler
Journal:  Eur Spine J       Date:  2016-07-15       Impact factor: 3.134

9.  Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease.

Authors:  Nadeeka N W Dissanayaka; Elizabeth White; John D O'Sullivan; Rodney Marsh; Peter A Silburn; David A Copland; George D Mellick; Gerard J Byrne
Journal:  Mov Disord Clin Pract       Date:  2015-04-06

10.  Effectiveness of a dance-physiotherapy combined intervention in Parkinson's disease: a randomized controlled pilot trial.

Authors:  Elisa Frisaldi; Piero Bottino; Margherita Fabbri; Marco Trucco; Alessandra De Ceglia; Nadia Esposito; Diletta Barbiani; Eleonora Maria Camerone; Federico Costa; Cristina Destefanis; Edoardo Milano; Giuseppe Massazza; Maurizio Zibetti; Leonardo Lopiano; Fabrizio Benedetti
Journal:  Neurol Sci       Date:  2021-03-20       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.